Vitamin D, magnesium, and iron deficiencies are frequently documented in patients on long-term GLP-1 therapy
Available in 3 mg, 7 mg, and 14 mg tablets, Rybelsus is a reasonable option if the logistics of transporting injectable medication concern you
GLP-1 receptor agonists have been studied in clinical trials and have shown significant weight loss benefits for certain patients when combined with diet and exercise
Research published in the British Journal of Pharmacology demonstrated that molecular conjugation of B12 (specifically the corrin ring structure found in cyanocobalamin) with GLP-1 receptor agonists produced a compound that was not as readily absorbed into the brainstem areas responsible for triggering nausea
Search strategy A systematic search was conducted across various databases and registers, including MEDLINE (via PubMed), Scopus, Cochrane Central Register, and ClinicalTrials.gov